Patents by Inventor Michael L. Hancock

Michael L. Hancock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTIVE ANDROGEN RECEPTOR MODULATOR AND CHEMOTHERAPEUTIC AGENT FOR TREATING MUSCLE WASTING IN CANCER PATIENTS
    Publication number: 20140134274
    Abstract: This invention provides use of a SARM compound or a composition comprising the same in treating and preventing muscle wasting in patients with non-small cell lung cancer (NSCLC); treating pre-cachexia or early cachexia (preventing muscle wasting in a cancer patient); treating and preventing loss of physical function due to cancer or cancer therapy; increase of physical function; and increasing survival in a patient with NSCLC, wherein the patients are subjected to cancer therapy.
    Type: Application
    Filed: October 24, 2013
    Publication date: May 15, 2014
    Applicant: University of Tennessee Research Foundation
    Inventors: Mitchell S. Steiner, Mary Ann Johnston, Michael L. Hancock, Jeffrey G. Hesselberg, James T. Dalton